Articles

Researchers study the health and economics issues associated with cognitive decline and dementia, and particularly the inequitable burden of Alzheimer’s.

Schaeffer experts submitted a comment letter responding to a recent request for information (RFI) regarding medical payment products.

A new study from the USC Schaeffer Center and Harvard University is the first to examine the “revolving door” in health care.

Since 2012, the Schaeffer Center has received $6.1 million in funding from the NIH to fund pilot projects by junior scholars focused on addressing disparities. This year we are seeking junior scientists concentrating on Alzheimer’s disease and related dementias in minority populations.

Medicare released the list of the first 10 drugs subject to price negotiations under the Inflation Reduction Act (IRA), aiming to reduce drug costs for Medicare enrollees and taxpayers.

Eleven Schaeffer fellows cosigned a comment letter to Centers for Medicaid and Medicare Services providing recommendations on the proposed Coverage with Evidence Development Guidance.

‘Forgotten middle’ Americans face poorer health, worse economic outcomes and lower homeownership rates, along with increased disability in old age.

The Biden administration’s efforts to regulate, either explicitly or through indirect government coercion, what it deems to be “misinformation” in healthcare not only runs counter to our shared values but can be dangerous to our health.

Schaeffer experts submitted a comment letter responding to a recent request for information (RFI) related to cannabidiol.

USC Schaeffer Center research finds intensive lifestyle intervention for people with type 2 diabetes – including weekly counseling on diet and exercise – is associated with increased employment. Researchers say the results suggest the potential of better chronic disease management for improving long-term labor market outcomes.